Allstate Corp Bristol Myers Squibb CO Transaction History

Allstate Corp

$1.2 Billion
Q2 2024

A detailed history of Allstate Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Allstate Corp holds 6,088 shares of BMY stock, worth $328,508. This represents 0.02% of its overall portfolio holdings.

Number of Shares

6,088

Holding current value

$328,508

% of portfolio

0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$40.25 - $52.99 $245,042 - $322,603	6,088 New	6,088 $252,000
Q4 2023 Feb 09, 2024	SELL	$48.48 - $57.85 $54,152 - $64,618	-1,117 Reduced 16.98%	5,460 $280,000
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $15,162 - $16,836	-238 Reduced 3.49%	6,577 $420,000
Q1 2023 May 10, 2023	SELL	$65.71 - $74.53 $6.82 Million - $7.73 Million	-103,714 Reduced 93.83%	6,815 $472,000
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $33,007 - $39,085	482 Added 0.44%	110,529 $7.95 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $80 - $47,487	-618 Reduced 0.56%	110,047 $7.82 Million
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $2.22 Million - $2.45 Million	-30,614 Reduced 21.67%	110,665 $8.52 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $4.14 Million - $4.96 Million	-67,275 Reduced 32.26%	141,279 $10.3 Million
Q4 2021 Feb 15, 2022	BUY	$53.63 - $62.52 $8.78 Million - $10.2 Million	163,747 Added 365.45%	208,554 $13 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $216,207 - $253,258	-3,654 Reduced 7.54%	44,807 $2.65 Million
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $193,468 - $210,687	-3,125 Reduced 6.06%	48,461 $3.24 Million
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $26,346 - $29,632	444 Added 0.87%	51,586 $3.26 Million
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $247,242 - $280,171	4,282 Added 9.14%	51,142 $3.17 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $1.07 Million - $1.19 Million	-18,711 Reduced 28.54%	46,860 $2.83 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $468,711 - $547,969	8,550 Added 14.99%	65,571 $3.86 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $3.79 Million - $5.51 Million	-81,744 Reduced 58.91%	57,021 $3.18 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $5.47 Million - $7.13 Million	111,153 Added 402.55%	138,765 $8.91 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $5.21 Million - $6.18 Million	-121,778 Reduced 81.52%	27,612 $1.4 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $2.88 Million - $3.18 Million	64,551 Added 76.09%	149,390 $6.78 Million
Q1 2019 May 20, 2019	SELL	$45.12 - $53.8 $1.13 Million - $1.35 Million	-25,098 Reduced 22.83%	84,839 $4.05 Million
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $5.36 Million - $6.95 Million	109,937 New	109,937 $5.72 Million

Others Institutions Holding BMY

# of Institutions

2,407

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$10.1 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.56 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.93 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$4.03 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.19 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Corp with notifications on news.

Account